Christopher J. Sayed

2.5k citations
74 papers · 1.2k indexed · 3 hit papers · h-index 16

Impact in

  • Dermatology top 0.2%
    • Hidradenitis Suppurativa and Treatments
    • Chemotherapy-related skin toxicity
    • Dermatology and Skin Diseases
  • Surgery top 5%
    • Colorectal and Anal Carcinomas
    • Anorectal Disease Treatments and Outcomes

Papers in

    • Hidradenitis Suppurativa and Treatments 60
    • Chemotherapy-related skin toxicity 13
    • Colorectal and Anal Carcinomas 49
    • Anorectal Disease Treatments and Outcomes 14

Christopher J. Sayed

62 papers receiving 1.2k citations

Hit Papers

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials 2024 · 71 citations
710+2+4Years since publication50100150200

Peers

Christopher J. Sayed
Comparison fields: 5 of 69
  • Dermatology 1.1k
  • Surgery 889
  • Epidemiology 357
  • Periodontics 15
  • Rheumatology 36
Replace Dagmar Presser with:
Dagmar Presser Germany
Carl Vinciullo Australia
Roel E. Genders Netherlands
Baruch Kaplan Israel
Francesca Boggio Italy
Jason C. Reutter United States
Gonca Gökdemir Türkiye
Francisco Javier García‐Martínez Spain
Robert Paver Australia
M C Fariña Spain
Christopher J. Sayed relative to Dagmar Presser Germany Dagmar Presser's profile →
Citations per field
00.5×6.7×
Dagmar Presser · 1×
Citations per year

Countries citing papers authored by Christopher J. Sayed

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Sayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Sayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Sayed more than expected).

Fields of papers citing papers by Christopher J. Sayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Sayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Sayed. The network helps show where Christopher J. Sayed may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher J. Sayed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher J. Sayed Line = papers co-authored together Christopher J. Sayed links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.

#Work
1
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
Hit paper breakdown →
2019224
2
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
Hit paper breakdown →
2019222
3 2021112
4
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
Hit paper breakdown →
202471
5 202060
6 202149
7 201942
8
Non-response to Interleukin-1 Antagonist Canakinumab in Two Patients with Refractory Pyoderma Gangrenosum and Hidradenitis Suppurativa.
201735
9 202230
10 202330
11 201926
12 202222
13 202117
14 202116
15 201615
16 202015
17 202113
18 202311
19 202111
20 202111

About Christopher J. Sayed

Christopher J. Sayed is a scholar working on Dermatology, Surgery, Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases, having authored 74 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hidradenitis Suppurativa and Treatments (60 papers), Colorectal and Anal Carcinomas (49 papers), Microscopic Colitis (14 papers), Anorectal Disease Treatments and Outcomes (14 papers), Chemotherapy-related skin toxicity (13 papers), Autoimmune and Inflammatory Disorders (6 papers), Streptococcal Infections and Treatments (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers). The work is most often cited by research in Dermatology (1.1k citations), Surgery (889 citations), Epidemiology (357 citations), Periodontics (15 citations) and Rheumatology (36 citations). Christopher J. Sayed has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Iltefat Hamzavi, Gregor B. E. Jemec, Joslyn S. Kirby, Alexa B. Kimball, Alice B. Gottlieb, Michelle A. Lowes, Afsáneh Alavi, Haley B. Naik, Craig N. Burkhart and Raed Alhusayen. Their work appears in journals such as Journal of the American Academy of Dermatology, JAMA Dermatology, Pediatric Dermatology, Dermatologic Surgery and British Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact